This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jabaily, J. Articles by Davis, J. N. Search for Related Content PubMed PubMed Citation Articles by Jabaily, J. Articles by Davis, J. N.

Stroke, Vol 15, 36-39, Copyright © 1984 by American Heart Association

ARTICLES

Naloxone administration to patients with acute stroke

J Jabaily and JN Davis

Naloxone, an opiate antagonist, has recently been reported to temporarily reverse neurologic deficits associated with subarachnoid hemorrhage. To determine if this unexpected effect of naloxone might also occur in other forms of cerebrovascular diseases, 13 patients who presented with acute neurologic deficits were administered intravenous naloxone. In 3 of these patients, coincidental improvement in neurologic status was seen. In one patient the improvement was permanent. Ten of the 11 patients with non fatal neurologic damage improved later in their hospital course--7 of them to their pre- admission state. The only side effect noted was the temporally related onset of a single focal seizure in an ethanol intoxicated patient with an intracerebral hemorrhage.

This article has been cited by other articles:

				H. Boutin, F. Dauphin, E. T. MacKenzie, P. Jauzac, and R. C. Koehler Differential Time-Course Decreases in Nonselective, µ-, {delta}-, and {kappa}-Opioid Receptors After Focal Cerebral Ischemia in Mice • Editorial Comment Stroke, June 1, 1999; 30(6): 1271 - 1278. [Abstract] [Full Text] [PDF]

				C. Tegeler and D. Sherman Analytic Review: Ischemic Cerebrovascular Disease: Diagnosis and Management J Intensive Care Med, July 1, 1986; 1(4): 184 - 196. [Abstract] [PDF]

				A. I. Faden Neuropeptides and Central Nervous System Injury: Clinical Implications Arch Neurol, May 1, 1986; 43(5): 501 - 504. [Abstract] [PDF]